Valuation: Mega Lifesciences

Market Cap 33.57B 1.01B 879M 824M 751M 1.41B 96.79B 1.43B 9.69B 3.79B 48.46B 3.81B 3.73B 162B P/E 2026 *
14.4x
P/E 2027 * 13.6x
Enterprise Value 28.96B 875M 758M 711M 648M 1.22B 83.49B 1.24B 8.36B 3.27B 41.81B 3.29B 3.22B 139B EV / Sales 2026 *
1.94x
EV / Sales 2027 * 1.84x
Free-Float
38.61%
Yield 2026 *
4.58%
Yield 2027 * 4.9%
1 day-0.65%
1 week-0.65%
Current month+1.32%
1 month+4.05%
3 months+8.45%
6 months-3.14%
Current year+14.93%
1 week 38.25
Extreme 38.25
39.5
1 month 36.5
Extreme 36.5
39.75
Current year 31.5
Extreme 31.5
40
1 year 27.75
Extreme 27.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 17.6
Extreme 17.6
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 62 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Date Insider Type Main position Quantity % Market Cap.
29/4/25 Buy

Chief Executive Officer

100,000 0.0115%
28/4/25 Buy

Chief Executive Officer

50,000 0.0057%
28/4/25 Buy

Chief Executive Officer

150,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
-0.65%-0.65%+26.23%-1.28% 1.01B
+0.49%+4.82%+91.77%+127.92% 1,083B
+0.35%+1.41%+51.19%+50.61% 626B
-0.80%+1.27%+25.52%+63.74% 442B
-0.92%+0.22%+48.34%+38.00% 363B
-1.32%-0.21%+29.07%+36.60% 295B
-1.20%-2.78%+5.56%+5.29% 248B
+0.60%+2.48%+46.66%+60.15% 224B
-2.51%+1.77%-6.55%-51.64% 210B
+0.78%+3.84%+14.00%+71.35% 168B
Average -0.53%+2.59%+33.18%+40.07% 366.01B
Weighted average by Cap. -0.21%+4.29%+49.63%+65.28%

Financials

2026 *2027 *
Net sales 14.91B 451M 391M 366M 334M 628M 43.01B 637M 4.31B 1.68B 21.53B 1.69B 1.66B 71.8B 15.69B 474M 411M 385M 351M 660M 45.24B 670M 4.53B 1.77B 22.65B 1.78B 1.74B 75.53B
Net income 2.33B 70.49M 61.07M 57.22M 52.19M 98.12M 6.72B 99.63M 673M 263M 3.37B 265M 259M 11.22B 2.47B 74.74M 64.76M 60.67M 55.34M 104M 7.13B 106M 714M 279M 3.57B 281M 275M 11.9B
Net Debt -4.61B -139M -121M -113M -103M -194M -13.3B -197M -1.33B -520M -6.66B -523M -512M -22.2B -4.76B -144M -125M -117M -107M -200M -13.72B -203M -1.37B -537M -6.87B -540M -529M -22.91B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
11/08/26 THB 38.50 -0.65% 466,665
10/08/26 THB 38.75 -1.27% 485,882
07/08/26 THB 39.25 +1.95% 1,072,151
06/08/26 THB 38.50 0.00% 796,791
05/08/26 THB 38.50 -0.65% 602,037
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
38.50THB
Average target price
42.43THB
Spread / Average Target
+10.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock